EDN1 and conjunctivitis: Kido-Nakahara et al. examined several serum biomarkers, including LDH, eosinophils, immunoglobulin E (IgE), and Endothelin-1 (ET-1), in relation to the development of dupilumab-associated conjunctivitis and blepharitis [28▪].